Liposomes are considered one of the most successful nanocarriers, usually composed of phospholipids, cholesterol, and drug components. Although traditional liposomes have made great progress, emerging shortcomings still affect the therapeutic index. Stimulus-responsive nano-delivery systems are increasingly being developed to improve drug delivery efficiency. With our expertise and technology accumulation in the field of liposomes, the scientific research team at CD Formulation can provide professional solutions for customizing and characterizing diverse environmentally Responsive Liposome, including magnetic responsive liposomes, PH-sensitive liposomes, photosensitive liposomes, temperature responsive liposomes, enzyme Responsive liposomes, etc.
Environmentally responsive liposomes generally can be divided into magnetic responsive liposomes, pH-sensitive liposomes, photosensitive liposomes, etc. pH or Redox-sensitive liposomes release drugs in response to weakly acidic pH and GSH, respectively, based on internal stimulation. PH-sensitive liposomes can mediate endosomal escape via proton sponges. Multifunctional liposomes that are responsive to both REDOX and pH have greater drug delivery capacity at tumor sites than pH or REDOX sensitivity alone. Magnetic fields and near-infrared radiation can be used for external stimulation of liposomes. Photoresponsive liposomes release drugs when exposed to radiation. Heat-sensitive liposomes release drugs at high temperatures >40°C. Magnetic-responsive liposomes release drugs in the presence of a magnetic field. These smart nanoliposomes can also mediate the co-delivery of drugs and genes in collaborative cancer therapy.
Fig.1 The schematic diagram of environmentally responsive liposomes. (Lee, Y I, et al., 2021)
At CD Formulation, we offer the following customized services.
Environmentally Responsive Liposome Customization |
Regarding the customization of environmentally responsive liposomes, the platforms and technologies available are as follows.
Items | Detailed Information |
Custom environmentally responsive liposome |
|
Analytical technologies |
|
In vivo and in vitro evaluation |
|
Technology: ROS-responsive liposomes with NIR light-triggered doxorubicin technique
Journal: Journal of Nanobiotechnology
IF: 10.2
Published: 2021
Results: In this study, the author developed a combined therapy nanoparticle system by coating ROS trigger and photosensitizer indocyanine green (ICG) and ROS-responsive doxorubicin (DOX) prodrug pB-DOX on polyethylene glycol-modified liposomes (Lipo/pB-DOX/ICG). The safety of the nanoparticle system was assessed on normal HEK-293 cells, while the cell uptake, intracellular ROS generation ability, target cell toxicity, and combined therapy effect were evaluated on human breast cancer cells MDA-MB-231. In vivo biodistribution, biocompatibility assessment, and combined therapy effect were studied based on the MDA-MB-231 subcutaneous tumor model. Compared with DOX·HCl, Lipo/pB-DOX/ICG exhibited higher safety to normal cells but showed much higher toxicity to the target cells than DOX·HCl, Lipo/pB-DOX, and Lipo/ICG. Therefore, Lipo/pB-DOX/ICG represents a novel approach for controlled drug release at the tumor site and holds promise as a candidate for precise combination cancer therapy.
Fig.2 Scheme illustration of ROS-responsive liposomes with NIR light-triggered doxorubicin. (Yi, H., et al. 2021)
As a global nanoparticle development company, CD Formulation has extensive experience in the development and customization of environmentally responsive liposomes. If you need any help, please do not hesitate to contact us.
References